Sofosbuvir + Velpatasvir在HCV基因3b型失代偿肝硬化患者中的非结构性5A耐药相关替代和白介素28b

Annals of Clinical and Medical Case Reports Pub Date : 1900-01-01 DOI:10.47829/acmcr.2021.71202

Kim Sk, F. T, Kim Sr, F. Y, Kobayashi H, H. T, O. T, N. A, Yuasa K, Takami M, Kim Ki, O. A, N. K, S. Y, Ogawa S, T. Y

{"title":"Sofosbuvir + Velpatasvir在HCV基因3b型失代偿肝硬化患者中的非结构性5A耐药相关替代和白介素28b","authors":"Kim Sk, F. T, Kim Sr, F. Y, Kobayashi H, H. T, O. T, N. A, Yuasa K, Takami M, Kim Ki, O. A, N. K, S. Y, Ogawa S, T. Y","doi":"10.47829/acmcr.2021.71202","DOIUrl":null,"url":null,"abstract":"Non-Structural 5A Resistance-Associated Substitutions and Interleukin28B in HCV Genotype 3b Decompensated Cirrhosis Patients with Sofosbuvir Plus Velpatasvir Kim SK1, Fujii T1*, Kim SR1, Fujii Y1, Kobayashi H2, Hayakumo T1, Okuda T1, Nakai A1, Yuasa K1, Takami M1, Kim KI3, Ohtani A3, Nakao K3, Saijo Y3, Ogawa S4, and Tanaka Y4,5 1*Department of Gastroenterology, Kobe Asahi Hospital, Kobe, 653-0801, Japan 2 Department of Radiology, Kobe Asahi Hospital, Kobe, 653-0801, Japan 3 Department of Pharmacy, Kobe Asahi Hospital, Kobe, 653-0801, Japan 4Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan 5Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, 860-8556, Japan","PeriodicalId":380321,"journal":{"name":"Annals of Clinical and Medical Case Reports","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Non-Structural 5A Resistance-Associated Substitutions and Interleukin28B in HCV Genotype 3b Decompensated Cirrhosis Patients with Sofosbuvir Plus Velpatasvir\",\"authors\":\"Kim Sk, F. T, Kim Sr, F. Y, Kobayashi H, H. T, O. T, N. A, Yuasa K, Takami M, Kim Ki, O. A, N. K, S. Y, Ogawa S, T. Y\",\"doi\":\"10.47829/acmcr.2021.71202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Non-Structural 5A Resistance-Associated Substitutions and Interleukin28B in HCV Genotype 3b Decompensated Cirrhosis Patients with Sofosbuvir Plus Velpatasvir Kim SK1, Fujii T1*, Kim SR1, Fujii Y1, Kobayashi H2, Hayakumo T1, Okuda T1, Nakai A1, Yuasa K1, Takami M1, Kim KI3, Ohtani A3, Nakao K3, Saijo Y3, Ogawa S4, and Tanaka Y4,5 1*Department of Gastroenterology, Kobe Asahi Hospital, Kobe, 653-0801, Japan 2 Department of Radiology, Kobe Asahi Hospital, Kobe, 653-0801, Japan 3 Department of Pharmacy, Kobe Asahi Hospital, Kobe, 653-0801, Japan 4Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan 5Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, 860-8556, Japan\",\"PeriodicalId\":380321,\"journal\":{\"name\":\"Annals of Clinical and Medical Case Reports\",\"volume\":\"22 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Clinical and Medical Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47829/acmcr.2021.71202\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical and Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47829/acmcr.2021.71202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

Sofosbuvir + Velpatasvir在HCV基因3b型失代偿肝硬化患者中的非结构性5A耐药相关替代和白细胞介素28b的研究Kim SK1, Fujii T1*， Kim SR1, Fujii Y1, Kobayashi H2, Hayakumo T1, Okuda T1, Nakai A1, Yuasa K1, Takami M1, Kim KI3, Ohtani A3, Nakao K3, Saijo Y3, Ogawa S4, Tanaka y4,5 1*神户朝日医院消化内科，神户，653-0801，日本神户，653-0801日本3神户朝日医院药剂科，神户653-0801;日本4名古屋市立大学医学研究生院病毒学与肝脏部，名古屋467-8601;日本5熊本大学生命科学学部消化与肝脏部，熊本860-8556

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Non-Structural 5A Resistance-Associated Substitutions and Interleukin28B in HCV Genotype 3b Decompensated Cirrhosis Patients with Sofosbuvir Plus Velpatasvir

Non-Structural 5A Resistance-Associated Substitutions and Interleukin28B in HCV Genotype 3b Decompensated Cirrhosis Patients with Sofosbuvir Plus Velpatasvir Kim SK1, Fujii T1*, Kim SR1, Fujii Y1, Kobayashi H2, Hayakumo T1, Okuda T1, Nakai A1, Yuasa K1, Takami M1, Kim KI3, Ohtani A3, Nakao K3, Saijo Y3, Ogawa S4, and Tanaka Y4,5 1*Department of Gastroenterology, Kobe Asahi Hospital, Kobe, 653-0801, Japan 2 Department of Radiology, Kobe Asahi Hospital, Kobe, 653-0801, Japan 3 Department of Pharmacy, Kobe Asahi Hospital, Kobe, 653-0801, Japan 4Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan 5Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, 860-8556, Japan

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of Clinical and Medical Case Reports

自引率

0.00%

发文量